NCT01800409

Brief Summary

Compromised respiratory function as a result of tetraplegia is a leading cause of rehospitalisation for the tetraplegic patient group. Electrical stimulation of the abdominal muscles has previously been used to improve the respiratory function of tetraplegic patients in the chronic stage of injury. In this study the investigators aim to evaluate the optimum protocol for the use of electrical stimulation of the abdominal muscles to improve the respiratory function of the tetraplegic population. The investigators also aim to investigate whether abdominal functional electrical stimulation combined with mechanical insufflation-exsufflation can be used to help further improve the respiratory function of the tetraplegic population.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2013

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2013

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

February 14, 2013

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 27, 2013

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

February 28, 2013

Status Verified

February 1, 2013

Enrollment Period

1.1 years

First QC Date

February 14, 2013

Last Update Submit

February 27, 2013

Conditions

Keywords

Tetraplegia

Outcome Measures

Primary Outcomes (1)

  • Respiratory function

    Forced Vital Capacity (FVC) tests will be performed with and without abdominal stimulation, which provides a measure of the participant's Vital Capacity (VC), Forced Exhaled Volume in one second (FEV1) and Peak Expiratory Flow (PEF). Respiratory flow and volume will be measured using a spirometer.

    at end of 8 week AFES intervention

Secondary Outcomes (3)

  • the total excursion of the diaphragm under both stimulated and unstimulated conditions

    at end of 8 week AFES intervention

  • the cough peak flow generated through unassisted MI-E, manually-assisted MI-E and AFES-assisted MI-E

    at end of 8 week AFES intervention

  • Patient's experience of using MI-E combined with AFES compared to the use of clinically established techniques

    at end of 8 week AFES intervention

Study Arms (2)

AFES training

EXPERIMENTAL

Participants will take part in AFES training sessions five times per week (Mon-Fri) for a total of 8 weeks During these sessions participants will receive AFES for 40 minutes. Training sessions are designed to strengthen the participants abdominal muscles in order to improve respiratory function

Device: AFES

Control period

NO INTERVENTION

Four week control period. The order of the control and training periods will be randomised for each participant.

Interventions

AFESDEVICE

During the stimulation sessions electrical stimulation will be applied for 40 minutes per day, 5 days per week for a total of 8 weeks

Also known as: neuromuscular stimulator (RehaStim, HasoMed, Germany)
AFES training

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Men or women over 16 years of age
  • Reduced respiratory function as a result of a cervical spinal cord injury
  • Good visual response to surface abdominal stimulation, suggesting that lower motor neurons are intact
  • Ventilator independent

You may not qualify if:

  • Under 16 years of age
  • Female subjects who are pregnant
  • Significant history of autonomic dysreflexia
  • No visual response to surface abdominal stimulation, suggesting that lower motor neurons are not intact
  • Unstable chest or abdominal injury
  • High levels of intrinsic PEEP (bulleous disease, lung tumour etc)
  • High anastomosis (e.g. oesophago-gastrectomy)
  • Bulbar dysfunction
  • Unable to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Elizabeth National Spinal Injuries Unit, Southern General Hospital

Glasgow, G51 4TF, United Kingdom

RECRUITING

Related Publications (12)

  • Cardozo CP. Respiratory complications of spinal cord injury. J Spinal Cord Med. 2007;30(4):307-8. doi: 10.1080/10790268.2007.11753945. No abstract available.

    PMID: 17853651BACKGROUND
  • Sancho J, Servera E, Vergara P, Marin J. Mechanical insufflation-exsufflation vs. tracheal suctioning via tracheostomy tubes for patients with amyotrophic lateral sclerosis: a pilot study. Am J Phys Med Rehabil. 2003 Oct;82(10):750-3. doi: 10.1097/01.PHM.0000087456.28979.2E.

    PMID: 14508404BACKGROUND
  • Sivasothy P, Brown L, Smith IE, Shneerson JM. Effect of manually assisted cough and mechanical insufflation on cough flow of normal subjects, patients with chronic obstructive pulmonary disease (COPD), and patients with respiratory muscle weakness. Thorax. 2001 Jun;56(6):438-44. doi: 10.1136/thorax.56.6.438.

    PMID: 11359958BACKGROUND
  • Bach JR. Mechanical insufflation-exsufflation. Comparison of peak expiratory flows with manually assisted and unassisted coughing techniques. Chest. 1993 Nov;104(5):1553-62. doi: 10.1378/chest.104.5.1553.

    PMID: 8222823BACKGROUND
  • Tzeng AC, Bach JR. Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest. 2000 Nov;118(5):1390-6. doi: 10.1378/chest.118.5.1390.

    PMID: 11083691BACKGROUND
  • Linn WS, Spungen AM, Gong H Jr, Adkins RH, Bauman WA, Waters RL. Forced vital capacity in two large outpatient populations with chronic spinal cord injury. Spinal Cord. 2001 May;39(5):263-8. doi: 10.1038/sj.sc.3101155.

    PMID: 11438842BACKGROUND
  • Bott J, Blumenthal S, Buxton M, Ellum S, Falconer C, Garrod R, Harvey A, Hughes T, Lincoln M, Mikelsons C, Potter C, Pryor J, Rimington L, Sinfield F, Thompson C, Vaughn P, White J; British Thoracic Society Physiotherapy Guideline Development Group. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax. 2009 May;64 Suppl 1:i1-51. doi: 10.1136/thx.2008.110726. No abstract available.

    PMID: 19406863BACKGROUND
  • Cheng PT, Chen CL, Wang CM, Chung CY. Effect of neuromuscular electrical stimulation on cough capacity and pulmonary function in patients with acute cervical cord injury. J Rehabil Med. 2006 Jan;38(1):32-6. doi: 10.1080/16501970510043387.

    PMID: 16548084BACKGROUND
  • Sorli J, Kandare F, Jaeger RJ, Stanic U. Ventilatory assistance using electrical stimulation of abdominal muscles. IEEE Trans Rehabil Eng. 1996 Mar;4(1):1-6. doi: 10.1109/86.486051.

    PMID: 8798066BACKGROUND
  • Jaeger RJ, Turba RM, Yarkony GM, Roth EJ. Cough in spinal cord injured patients: comparison of three methods to produce cough. Arch Phys Med Rehabil. 1993 Dec;74(12):1358-61. doi: 10.1016/0003-9993(93)90093-p.

    PMID: 8018145BACKGROUND
  • Langbein WE, Maloney C, Kandare F, Stanic U, Nemchausky B, Jaeger RJ. Pulmonary function testing in spinal cord injury: effects of abdominal muscle stimulation. J Rehabil Res Dev. 2001 Sep-Oct;38(5):591-7.

    PMID: 11732836BACKGROUND
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. doi: 10.1183/09031936.05.00034805. No abstract available.

    PMID: 16055882BACKGROUND

MeSH Terms

Conditions

Quadriplegia

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Henrik Gollee, PhD

    University of Glasgow

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2013

First Posted

February 27, 2013

Study Start

February 1, 2013

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

February 28, 2013

Record last verified: 2013-02

Locations